Chronic Kidney Disease - REAL Life Study in Alsace
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Kidney Diseases
- Sponsor
- University Hospital, Strasbourg, France
- Enrollment
- 3000
- Locations
- 1
- Primary Endpoint
- Retroanalysis of the risk factors in patients with severe chronic kidney disease
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry).
Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage.
Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Retroanalysis of the risk factors in patients with severe chronic kidney disease
Time Frame: Files analysed retrospectively from October 01, 2019 to February 31, 2027 will be examined
Analysis of risk factors in patients with severe chronic kidney disease by retrospectively analyzing health data contained in patient medical records